MedTrace Logo

The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor.

NCT04408937 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2022-02-09

No results posted yet for this study

Summary

The purpose of this study is to determine whether dosing tropifexor is safe and tolerable.

Conditions

Interventions

DRUG

triopifexor

Tropifexor as a dry blend in hard gelatin capsules for oral administration

DRUG

Placebo

Placebo capsules for oral administration

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-29
Primary Completion
2020-11-04
Completion
2020-11-04
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04408937 on ClinicalTrials.gov